{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T18:23:15Z","timestamp":1794853395753,"version":"4.9.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T00:00:00Z","timestamp":1780790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T00:00:00Z","timestamp":1794787200000},"content-version":"vor","delay-in-days":162,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31902297"],"award-info":[{"award-number":["31902297"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32072891"],"award-info":[{"award-number":["32072891"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32373039"],"award-info":[{"award-number":["32373039"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31672546"],"award-info":[{"award-number":["31672546"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Liaoning Provincial Science and Technology Joint Program","award":["2025-MSLH-610"],"award-info":[{"award-number":["2025-MSLH-610"]}]},{"name":"Ongoing Research Funding Program-Research chairs","award":["ORF-RC-2026-4500"],"award-info":[{"award-number":["ORF-RC-2026-4500"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"DOI":"10.1186\/s13071-026-07454-6","type":"journal-article","created":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T05:23:16Z","timestamp":1780809796000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Gene-edited live-attenuated vaccines against Toxoplasma gondii: recent advances and future frontiers"],"prefix":"10.1186","volume":"19","author":[{"given":"Xiaoyu","family":"Sang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanting","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangqi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ebtesam","family":"Al-Olayan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"},{"role":"corresponding-author","vocabulary":"crossref"}]},{"given":"Saeed","family":"El-Ashram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"},{"role":"corresponding-author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,6,7]]},"reference":[{"key":"7454_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/01652176.2024.2396577","volume":"44","author":"A Mohammed","year":"2024","unstructured":"Mohammed A, Ahmed M, Ibrahim N. The global seroprevalence of Toxoplasma gondii infection in workers occupationally exposed to animals (1972\u20132023): a systematic review and meta-analysis. Vet Q. 2024;44:1\u201318. https:\/\/doi.org\/10.1080\/01652176.2024.2396577.","journal-title":"Vet Q"},{"key":"7454_CR2","first-page":"898","volume":"36","author":"A Molan","year":"2019","unstructured":"Molan A, Nosaka K, Hunter M, Wang W. Global status of Toxoplasma gondii infection: systematic review and prevalence snapshots. Trop Biomed. 2019;36:898\u2013925.","journal-title":"Trop Biomed"},{"key":"7454_CR3","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1186\/s13071-020-04445-z","volume":"13","author":"M Attias","year":"2020","unstructured":"Attias M, Teixeira DE, Benchimol M, Vommaro RC, Crepaldi PH, De Souza W. The life-cycle of Toxoplasma gondii reviewed using animations. Parasit Vectors. 2020;13:588. https:\/\/doi.org\/10.1186\/s13071-020-04445-z.","journal-title":"Parasit Vectors"},{"key":"7454_CR4","doi-asserted-by":"publisher","first-page":"e00115","DOI":"10.1128\/CMR.00115-19","volume":"34","author":"HM Elsheikha","year":"2020","unstructured":"Elsheikha HM, Marra CM, Zhu XQ. Epidemiology, pathophysiology, diagnosis, and management of cerebral toxoplasmosis. Clin Microbiol Rev. 2020;34:e00115-e119. https:\/\/doi.org\/10.1128\/CMR.00115-19.","journal-title":"Clin Microbiol Rev"},{"key":"7454_CR5","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1128\/CMR.05013-11","volume":"25","author":"F Robert-Gangneux","year":"2012","unstructured":"Robert-Gangneux F, Dard\u00e9 ML. Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev. 2012;25:583\u201393. https:\/\/doi.org\/10.1128\/CMR.05013-11.","journal-title":"Clin Microbiol Rev"},{"key":"7454_CR6","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s00281-012-0339-3","volume":"34","author":"CD Dupont","year":"2012","unstructured":"Dupont CD, Christian DA, Hunter CA. Immune response and immunopathology during toxoplasmosis. Semin Immunopathol. 2012;34:793\u2013813. https:\/\/doi.org\/10.1007\/s00281-012-0339-3.","journal-title":"Semin Immunopathol"},{"key":"7454_CR7","doi-asserted-by":"publisher","first-page":"894573","DOI":"10.3389\/fped.2022.894573","volume":"10","author":"L Bollani","year":"2022","unstructured":"Bollani L, Auriti C, Achille C, Garofoli F, De Rose DU, Meroni V, et al. Congenital toxoplasmosis: the state of the art. Front Pediatr. 2022;10:894573. https:\/\/doi.org\/10.3389\/fped.2022.894573.","journal-title":"Front Pediatr"},{"key":"7454_CR8","doi-asserted-by":"publisher","first-page":"501","DOI":"10.2471\/BLT.12.111732","volume":"91","author":"PR Torgerson","year":"2013","unstructured":"Torgerson PR, Mastroiacovo P. The global burden of congenital toxoplasmosis: a systematic review. Bull World Health Organ. 2013;91:501\u20138. https:\/\/doi.org\/10.2471\/BLT.12.111732.","journal-title":"Bull World Health Organ"},{"key":"7454_CR9","doi-asserted-by":"publisher","first-page":"e00037","DOI":"10.1016\/j.fawpar.2019.e00037","volume":"15","author":"S Stelzer","year":"2019","unstructured":"Stelzer S, Basso W, Benavides Silvan J, Ortega-Mora LM, Maksimov P, Gethmann J, et al. Toxoplasma gondii infection and toxoplasmosis in farm animals: risk factors and economic impact. Food Waterborne Parasitol. 2019;15:e00037. https:\/\/doi.org\/10.1016\/j.fawpar.2019.e00037.","journal-title":"Food Waterborne Parasitol"},{"key":"7454_CR10","doi-asserted-by":"publisher","first-page":"e00057","DOI":"10.1128\/CMR.00057-17","volume":"31","author":"IR Dunay","year":"2018","unstructured":"Dunay IR, Gajurel K, Dhakal R, Liesenfeld O, Montoya JG. Treatment of toxoplasmosis: historical perspective, animal models, and current clinical practice. Clin Microbiol Rev. 2018;31:e00057-e117. https:\/\/doi.org\/10.1128\/CMR.00057-17.","journal-title":"Clin Microbiol Rev"},{"key":"7454_CR11","doi-asserted-by":"publisher","first-page":"4902","DOI":"10.3390\/ijms24054902","volume":"24","author":"MQ Li","year":"2023","unstructured":"Li MQ, Sang XY, Zhang XH, Li X, Feng Y, Yang N, et al. A metabolomic and transcriptomic study revealed the mechanisms of lumefantrine inhibition of Toxoplasma gondii. Int J Mol Sci. 2023;24:4902. https:\/\/doi.org\/10.3390\/ijms24054902.","journal-title":"Int J Mol Sci"},{"key":"7454_CR12","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1017\/S0031182020002036","volume":"148","author":"DW Wang","year":"2021","unstructured":"Wang DW, Xing MG, El-Ashram S, Ding YY, Zhang X, Sang XY, et al. Determination of lumefantrine as an effective drug against Toxoplasma gondii infection - an in vitro and in vivo study. Parasitology. 2021;148:122\u20138. https:\/\/doi.org\/10.1017\/S0031182020002036.","journal-title":"Parasitology"},{"key":"7454_CR13","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.1007\/s00436-018-6027-z","volume":"117","author":"M Montazeri","year":"2018","unstructured":"Montazeri M, Mehrzadi S, Sharif M, Sarvi S, Shahdin S, Daryani A. Activities of anti-Toxoplasma drugs and compounds against tissue cysts in the last three decades (1987 to 2017), a systematic review. Parasitol Res. 2018;117:3045\u201357. https:\/\/doi.org\/10.1007\/s00436-018-6027-z.","journal-title":"Parasitol Res"},{"key":"7454_CR14","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.3390\/vaccines11111678","volume":"11","author":"X Li","year":"2023","unstructured":"Li X, Yuan W, He T, Guo RY, Du XX, He YH, et al. Boosting mouse defense against lethal Toxoplasma gondii infection with full-length and soluble SAG1 recombinant protein. Vaccines. 2023;11:1678. https:\/\/doi.org\/10.3390\/vaccines11111678.","journal-title":"Vaccines"},{"key":"7454_CR15","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.3390\/vaccines11071190","volume":"11","author":"XY Sang","year":"2023","unstructured":"Sang XY, Li X, Chen R, Feng Y, He T, Zhang XH, et al. Co-immunization with DNA vaccines expressing SABP1 and SAG1 proteins effectively enhanced mice resistance to Toxoplasma gondii acute infection. Vaccines. 2023;11:1190. https:\/\/doi.org\/10.3390\/vaccines11071190.","journal-title":"Vaccines"},{"key":"7454_CR16","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3390\/vaccines9050413","volume":"9","author":"KB Chu","year":"2021","unstructured":"Chu KB, Quan FS. Advances in Toxoplasma gondii vaccines: current strategies and challenges for vaccine development. Vaccines. 2021;9:413. https:\/\/doi.org\/10.3390\/vaccines9050413.","journal-title":"Vaccines"},{"key":"7454_CR17","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1017\/S003118200000144X","volume":"110","author":"D Buxton","year":"1995","unstructured":"Buxton D, Innes EA. A commercial vaccine for ovine toxoplasmosis. Parasitology. 1995;110:S11\u20136. https:\/\/doi.org\/10.1017\/S003118200000144X.","journal-title":"Parasitology"},{"key":"7454_CR18","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3390\/pathogens13020121","volume":"13","author":"HS Zhang","year":"2024","unstructured":"Zhang HS, Cao H, Li CX, Zhang ZW, Wang M, Zhu XQ, et al. Immunization with live-attenuated RH\u0394had2a strain confers partial protective immunity against acute and chronic infection of Toxoplasma gondii in mice. Pathogens. 2024;13:121. https:\/\/doi.org\/10.3390\/pathogens13020121.","journal-title":"Pathogens"},{"key":"7454_CR19","doi-asserted-by":"publisher","first-page":"e01114","DOI":"10.1128\/mBio.01114-14","volume":"5","author":"B Shen","year":"2014","unstructured":"Shen B, Brown KM, Lee TD, Sibley LD. Efficient gene disruption in diverse strains of Toxoplasma gondii using CRISPR\/Cas9. MBio. 2014;5:e01114. https:\/\/doi.org\/10.1128\/mBio.01114-14.","journal-title":"MBio"},{"key":"7454_CR20","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1186\/s13071-024-06461-9","volume":"17","author":"J Li","year":"2024","unstructured":"Li J, Kang Y, Wu ZX, Yang SF, Tian YY, Zhu XQ, et al. Live-attenuated Pru\u0394gra72 strain of Toxoplasma gondii induces strong protective immunity against acute and chronic toxoplasmosis in mice. Parasites Vectors. 2024;17:377. https:\/\/doi.org\/10.1186\/s13071-024-06461-9.","journal-title":"Parasites Vectors"},{"key":"7454_CR21","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41541-024-00996-9","volume":"9","author":"C Wang","year":"2024","unstructured":"Wang C, Fu SN, Yu X, Zhou H, Zhang FM, Song LL, et al. Toxoplasma WH3\u0394rop18 acts as a live attenuated vaccine against acute and chronic toxoplasmosis. npj Vaccines. 2024;9:197. https:\/\/doi.org\/10.1038\/s41541-024-00996-9.","journal-title":"npj Vaccines"},{"key":"7454_CR22","doi-asserted-by":"publisher","first-page":"104714","DOI":"10.1016\/j.ijpara.2025.08.002","volume":"56","author":"SC Xie","year":"2025","unstructured":"Xie SC, Lv YH, Wang M, Zheng XN, Wang JL, Fu BQ, et al. Live-attenuated Toxoplasma gondii Pru\u0394pp2a-c mutant elicits protective immunity against toxoplasmosis in mice and cats. Int J Parasitol. 2025;56:104714. https:\/\/doi.org\/10.1016\/j.ijpara.2025.08.002.","journal-title":"Int J Parasitol"},{"key":"7454_CR23","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/j.cell.2016.08.019","volume":"166","author":"SM Sidik","year":"2016","unstructured":"Sidik SM, Huet D, Ganesan SM, Huynh MH, Wang T, Nasamu AS, et al. A genome-wide CRISPR screen in Toxoplasma identifies essential apicomplexan genes. Cell. 2016;166:1423-1435.e12. https:\/\/doi.org\/10.1016\/j.cell.2016.08.019.","journal-title":"Cell"},{"key":"7454_CR24","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3389\/fmicb.2020.00258","volume":"11","author":"N Yang","year":"2020","unstructured":"Yang N, Xing MG, Ding YY, Wang DW, Guo XG, Sang XY, et al. The putative TCP-1 chaperonin is an important player involved in sialic acid-dependent host cell invasion by Toxoplasma gondii. Front Microbiol. 2020;11:258. https:\/\/doi.org\/10.3389\/fmicb.2020.00258.","journal-title":"Front Microbiol"},{"key":"7454_CR25","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1146\/annurev-micro-091014-104100","volume":"69","author":"IJ Blader","year":"2015","unstructured":"Blader IJ, Coleman BI, Chen CT, Gubbels MJ. The lytic cycle of Toxoplasma gondii: 15 years later. Annu Rev Microbiol. 2015;69:463\u201385. https:\/\/doi.org\/10.1146\/annurev-micro-091014-104100.","journal-title":"Annu Rev Microbiol"},{"key":"7454_CR26","doi-asserted-by":"publisher","first-page":"e03081","DOI":"10.1128\/mbio.03081-23","volume":"15","author":"MA Bitew","year":"2024","unstructured":"Bitew MA, Gaete PS, Swale C, Maru P, Contreras JE, Saeij JPJ. Two Toxoplasma gondii putative pore-forming proteins, GRA47 and GRA72, influence small molecule permeability of the parasitophorous vacuole. MBio. 2024;15:e03081. https:\/\/doi.org\/10.1128\/mbio.03081-23.","journal-title":"MBio"},{"key":"7454_CR27","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ijpara.2023.09.001","volume":"54","author":"XN Zheng","year":"2024","unstructured":"Zheng XN, Sun LX, Elsheikha HM, Li TT, Gao J, Wu XJ, et al. A newly characterized dense granule protein (GRA76) is important for the growth and virulence of Toxoplasma gondii. Int J Parasitol. 2024;54:109\u201321. https:\/\/doi.org\/10.1016\/j.ijpara.2023.09.001.","journal-title":"Int J Parasitol"},{"key":"7454_CR28","doi-asserted-by":"publisher","first-page":"1173379","DOI":"10.3389\/fimmu.2023.1173379","volume":"14","author":"M Chen","year":"2023","unstructured":"Chen M, Yang P, Xin ZX, Chen JT, Zou WH, Zhou LJ, et al. Toxoplasma gondii gra5 deletion mutant protects hosts against Toxoplasma gondii infection and breast tumors. Front Immunol. 2023;14:1173379. https:\/\/doi.org\/10.3389\/fimmu.2023.1173379.","journal-title":"Front Immunol"},{"key":"7454_CR29","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1126\/science.1133643","volume":"314","author":"S Taylor","year":"2006","unstructured":"Taylor S, Barragan A, Su C, Fux B, Fentress SJ, Tang K, et al. A secreted serine-threonine kinase determines virulence in the eukaryotic pathogen Toxoplasma gondii. Science. 2006;314:1776\u201380. https:\/\/doi.org\/10.1126\/science.1133643.","journal-title":"Science"},{"key":"7454_CR30","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s40249-023-01109-9","volume":"12","author":"Y Shen","year":"2023","unstructured":"Shen Y, Zheng B, Sun H, Wu SR, Fan JY, Ding JZ, et al. A live attenuated RH\u0394ompdc\u0394uprt mutant of Toxoplasma gondii induces strong protective immunity against toxoplasmosis in mice and cats. Infect Dis Poverty. 2023;12:60. https:\/\/doi.org\/10.1186\/s40249-023-01109-9.","journal-title":"Infect Dis Poverty"},{"key":"7454_CR31","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1111\/1751-7915.14324","volume":"16","author":"QH Guo","year":"2023","unstructured":"Guo QH, Guo XF, Ji N, Shen B, Zhong XH, Xiao LH, et al. Role of 6-phosphogluconate dehydrogenase enzyme 1 in growth and virulence of Toxoplasma gondii and development of attenuated live vaccine. Microb Biotechnol. 2023;16:1957\u201370. https:\/\/doi.org\/10.1111\/1751-7915.14324.","journal-title":"Microb Biotechnol"},{"key":"7454_CR32","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3390\/vaccines8010016","volume":"8","author":"LY Wang","year":"2020","unstructured":"Wang LY, Tang D, Yang CH, Yang J, Fang R. Toxoplasma gondii ADSL knockout provides excellent immune protection against a variety of strains. Vaccines. 2020;8:16. https:\/\/doi.org\/10.3390\/vaccines8010016.","journal-title":"Vaccines"},{"key":"7454_CR33","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41541-022-00518-5","volume":"7","author":"MM Wu","year":"2022","unstructured":"Wu MM, Liu ST, Chen Y, Liu D, An R, Cai HJ, et al. Live-attenuated ME49\u0394cdpk3 strain of Toxoplasma gondii protects against acute and chronic toxoplasmosis. npj Vaccines. 2022;7:98. https:\/\/doi.org\/10.1038\/s41541-022-00518-5.","journal-title":"npj Vaccines"},{"key":"7454_CR34","doi-asserted-by":"publisher","first-page":"e70143","DOI":"10.1111\/1751-7915.70143","volume":"18","author":"YF Luo","year":"2025","unstructured":"Luo YF, He MF, Yang SQ, Qian JH, He ZM, Xu JY, et al. Toxoplasma gondii C2 domain protein deletion mutant as a promising vaccine against toxoplasmosis in mice. Microb Biotechnol. 2025;18:e70143. https:\/\/doi.org\/10.1111\/1751-7915.70143.","journal-title":"Microb Biotechnol"},{"key":"7454_CR35","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/nrmicro2858","volume":"10","author":"CA Hunter","year":"2012","unstructured":"Hunter CA, Sibley LD. Modulation of innate immunity by Toxoplasma gondii virulence effectors. Nat Rev Microbiol. 2012;10:766\u201378. https:\/\/doi.org\/10.1038\/nrmicro2858.","journal-title":"Nat Rev Microbiol"},{"key":"7454_CR36","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nri3598","volume":"14","author":"F Yarovinsky","year":"2014","unstructured":"Yarovinsky F. Innate immunity to Toxoplasma gondii infection. Nat Rev Immunol. 2014;14:109\u201321. https:\/\/doi.org\/10.1038\/nri3598.","journal-title":"Nat Rev Immunol"},{"key":"7454_CR37","doi-asserted-by":"publisher","first-page":"798","DOI":"10.4049\/jimmunol.157.2.798","volume":"157","author":"RT Gazzinelli","year":"1996","unstructured":"Gazzinelli RT, Wysocka M, Hieny S, Scharton-Kersten T, Cheever A, Kuhn R, et al. In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-\u03b3 and TNF-\u03b1. J Immunol. 1996;157:798\u2013805.","journal-title":"J Immunol"},{"key":"7454_CR38","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.2353\/ajpath.2010.090825","volume":"176","author":"Y Suzuki","year":"2010","unstructured":"Suzuki Y, Wang XS, Jortner BS, Payne L, Ni YY, Michie SA, et al. Removal of Toxoplasma gondii cysts from the brain by perforin-mediated activity of CD8+ T cells. Am J Pathol. 2010;176:1607\u201313. https:\/\/doi.org\/10.2353\/ajpath.2010.090825.","journal-title":"Am J Pathol"},{"key":"7454_CR39","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1128\/iai.68.3.1026-1033.2000","volume":"68","author":"PC Sayles","year":"2000","unstructured":"Sayles PC, Gibson GW, Johnson LL. B cells are essential for vaccination-induced resistance to virulent Toxoplasma gondii. Infect Immun. 2000;68:1026\u201333. https:\/\/doi.org\/10.1128\/iai.68.3.1026-1033.2000.","journal-title":"Infect Immun"},{"key":"7454_CR40","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1111\/1751-7915.13668","volume":"13","author":"J Yang","year":"2020","unstructured":"Yang J, Yang CH, Qian JH, Li FC, Zhao JL, Fang R. Toxoplasma gondii \u03b1-amylase deletion mutant is a promising vaccine against acute and chronic toxoplasmosis. Microb Biotechnol. 2020;13:2057\u201368. https:\/\/doi.org\/10.1111\/1751-7915.13668.","journal-title":"Microb Biotechnol"},{"key":"7454_CR41","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1590\/S0074-02762009000200019","volume":"104","author":"E Jongert","year":"2009","unstructured":"Jongert E, Roberts CW, Gargano N, F\u00f6rster-Waldl E, Petersen E. Vaccines against Toxoplasma gondii: challenges and opportunities. Mem Inst Oswaldo Cruz. 2009;104:252\u201366. https:\/\/doi.org\/10.1590\/S0074-02762009000200019.","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"7454_CR42","doi-asserted-by":"publisher","first-page":"607198","DOI":"10.3389\/fcimb.2020.607198","volume":"10","author":"MN M\u00e9v\u00e9lec","year":"2020","unstructured":"M\u00e9v\u00e9lec MN, Lakhrif Z, Dimier-Poisson I. Key limitations and new insights into the Toxoplasma gondii parasite stage switching for future vaccine development in human, livestock, and cats. Front Cell Infect Microbiol. 2020;10:607198. https:\/\/doi.org\/10.3389\/fcimb.2020.607198.","journal-title":"Front Cell Infect Microbiol"},{"key":"7454_CR43","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.pt.2019.01.005","volume":"35","author":"JL Wang","year":"2019","unstructured":"Wang JL, Zhang NZ, Li TT, He JJ, Elsheikha HM, Zhu XQ. Advances in the development of anti-Toxoplasma gondii vaccines: challenges, opportunities, and perspectives. Trends Parasitol. 2019;35:239\u201353. https:\/\/doi.org\/10.1016\/j.pt.2019.01.005.","journal-title":"Trends Parasitol"},{"key":"7454_CR44","doi-asserted-by":"publisher","first-page":"910961","DOI":"10.3389\/fimmu.2022.910961","volume":"13","author":"D Arranz-Sol\u00eds","year":"2022","unstructured":"Arranz-Sol\u00eds D, Saeij JPJ. New avenues to design Toxoplasma vaccines based on oocysts and cysts. Front Immunol. 2022;13:910961. https:\/\/doi.org\/10.3389\/fimmu.2022.910961.","journal-title":"Front Immunol"},{"key":"7454_CR45","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41541-022-00563-0","volume":"7","author":"YZ Zhang","year":"2022","unstructured":"Zhang YZ, Li D, Lu SH, Zheng B. Toxoplasmosis vaccines: what we have and where to go? npj Vaccines. 2022;7:131. https:\/\/doi.org\/10.1038\/s41541-022-00563-0.","journal-title":"npj Vaccines"},{"key":"7454_CR46","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1590\/S0074-02762009000200018","volume":"104","author":"EA Innes","year":"2009","unstructured":"Innes EA, Bartley PM, Maley S, Katzer F, Buxton D. Veterinary vaccines against Toxoplasma gondii. Mem Inst Oswaldo Cruz. 2009;104:246\u201351. https:\/\/doi.org\/10.1590\/S0074-02762009000200018.","journal-title":"Mem Inst Oswaldo Cruz"}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13071-026-07454-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-026-07454-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-026-07454-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T18:04:20Z","timestamp":1794852260000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13071-026-07454-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,7]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7454"],"URL":"https:\/\/doi.org\/10.1186\/s13071-026-07454-6","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,7]]},"assertion":[{"value":"9 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors approved the final manuscript.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"496"}}